Changhui Liu Selected Research

Insulin Resistance

1/2024	Antidiabetic effects and mechanism of γ-polyglutamic acid on type II diabetes mice.
8/2023	Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro.
5/2023	Ginsenosides Rc, as a novel SIRT6 activator, protects mice against high fat diet induced NAFLD.
11/2021	Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.
4/2020	Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1.
1/2020	Chrysophanol Alleviates Metabolic Syndrome by Activating the SIRT6/AMPK Signaling Pathway in Brown Adipocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Changhui Liu Research Topics

Disease

10	Inflammation (Inflammations) 01/2024 - 02/2016
6	Insulin Resistance 01/2024 - 01/2020
5	Colitis 09/2022 - 01/2018
4	Non-alcoholic Fatty Liver Disease 08/2023 - 06/2020
4	Neoplasms (Cancer) 03/2016 - 01/2015
3	Ulcerative Colitis 02/2024 - 02/2021
3	Cholestasis 01/2024 - 02/2020
3	Body Weight (Weight, Body) 09/2022 - 01/2020
2	Jaundice (Icterus) 04/2021 - 02/2016
2	Cholelithiasis 06/2020 - 11/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2020 - 01/2018
2	Intrahepatic Cholestasis 02/2020 - 02/2016
2	Alzheimer Disease (Alzheimer's Disease) 03/2014 - 01/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024
1	Carcinoma (Carcinomatosis) 12/2023
1	Melanoma (Melanoma, Malignant) 12/2023
1	AIDS-Related Complex (ARC) 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023
1	Pathologic Processes 10/2023
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 08/2023
1	Liver Diseases (Liver Disease) 05/2023
1	Glucose Intolerance 05/2023
1	Hemorrhage 01/2023
1	Acute Coronary Syndrome 01/2023
1	Dysbiosis 09/2022
1	Osteoporosis 08/2022
1	Hypertension (High Blood Pressure) 08/2022
1	Osteoporotic Fractures 08/2022
1	Arthritis (Polyarthritis) 08/2022
1	Necrosis 01/2022
1	Fatty Liver 11/2021
1	Calculi (Calculus) 03/2021
1	Diarrhea 01/2021
1	Dysentery 01/2021
1	Hepatitis 06/2020
1	Metabolic Diseases (Metabolic Disease) 04/2020
1	Digestive System Diseases 02/2020
1	Thrombosis (Thrombus) 01/2020

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 08/2023 - 01/2020
5	Dextrans (Dextran)FDA Link 09/2022 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 12/2014
4	Bile Acids and Salts (Bile Acids)IBA 01/2024 - 02/2020
4	Biomarkers (Surrogate Marker)IBA 02/2021 - 01/2012
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 09/2022 - 12/2020
3	geniposidic acidIBA 09/2022 - 02/2016
3	schaftosideIBA 10/2020 - 11/2017
2	Dextran SulfateIBA 02/2024 - 02/2021
2	Blood Glucose (Blood Sugar)IBA 01/2024 - 08/2023
2	AntioxidantsIBA 01/2024 - 05/2023
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 07/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2023 - 11/2021
2	GinsenosidesIBA 05/2023 - 04/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2023 - 11/2021
2	CytokinesIBA 09/2022 - 09/2022
2	Therapeutic UsesIBA 08/2022 - 01/2018
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022 - 10/2020
2	lidanIBA 04/2021 - 02/2020
2	nigakinoneIBA 02/2021 - 12/2020
2	SodiumIBA 02/2020 - 01/2018
2	Pregnane X ReceptorIBA 02/2020 - 01/2018
2	Silicon Dioxide (Silica)FDA LinkGeneric 06/2015 - 03/2015
1	Insulin (Novolin)FDA Link 01/2024
1	EnzymesIBA 01/2024
1	Prostaglandins AIBA 01/2024
1	gingerolIBA 01/2024
1	Amino Acids FDA Link 12/2023
1	Small Interfering RNA (siRNA)IBA 11/2023
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 11/2023
1	Cisplatin (Platino)FDA LinkGeneric 11/2023
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	Sulfur DioxideIBA 10/2023
1	typhaneosideIBA 08/2023
1	ginsenoside RcIBA 05/2023
1	Fatty AlcoholsIBA 05/2023
1	RivaroxabanIBA 01/2023
1	AnticoagulantsIBA 01/2023
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2023
1	OccludinIBA 09/2022
1	vitexinIBA 09/2022
1	Proteins (Proteins, Gene)FDA Link 09/2022
1	InflammasomesIBA 09/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 11/2021
1	Oleic Acid (Oleate)IBA 11/2021
1	Stimuli Responsive PolymersIBA 03/2021
1	Linoleic Acid (Linoleate)IBA 02/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 02/2021
1	Vitamin A (Retinol)FDA LinkGeneric 02/2021
1	SphingolipidsIBA 02/2021
1	EicosanoidsIBA 10/2020
1	FlavonoidsIBA 10/2020
1	ginsenoside Rg2IBA 04/2020
1	Sirtuin 1IBA 04/2020
1	Indicators and Reagents (Reagents)IBA 02/2020
1	Cholic AcidIBA 02/2020
1	chrysophanic acidIBA 01/2020

Therapy/Procedure

3	Therapeutics 01/2021 - 03/2015
1	Subcutaneous Injections 01/2024
1	Oral Administration 12/2020
1	Stents 01/2020